Phase II Trial of Gemcitabine and Genistein in Metastatic Breast Cancer Patients With Biomarker Assays.
Phase of Trial: Phase II
Latest Information Update: 21 May 2018
At a glance
- Drugs Gemcitabine (Primary) ; Genistein (Primary)
- Indications Advanced breast cancer
- Focus Biomarker; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 13 Mar 2012 Additional lead trial investigator (Amy Weise) identified as reported by ClinicalTrials.gov.
- 13 Mar 2012 Actual patient number is 19 according to ClinicalTrials.gov.